Pharmaceutical News and Articles

Comprehensive and up-to-date drug news for both consumers and healthcare professionals.

Global Warming's Heat Is Killing the World's Young

Heat waves caused by climate change have been thought to pose the greatest risk to the world s elderly, but a new study from Mexico suggests that s not the case

EPA Bans Two Solvents Linked to Cancer

Two commonly used solvents that have been linked to cancer were banned Monday by the Environmental Protection Agency. The solvents, known as trichloroethylene (

Trump Says RFK Jr. Free to Revisit Discredited Autism/Vaccine Link

If Robert F. Kennedy Jr. is approved to head the U.S. Department of Health and Human Services, he will be free to revisit a long-debunked link between autism an

Rilzabrutinib Demonstrated Significant Patient Benefit in the First Positive Phase 3 Study of a BTK Inhibitor in ITP

Paris, December 7, 2024. Positive results from the pivotal LUNA 3 phase 3 study of rilzabrutinib in adults with persistent or chronic immune thrombocytopenia (I

Novel Combination of Pozelimab and Cemdisiran (Poze-Cemdi) Achieved Greater Control of Intravascular Hemolysis in Patients with Paroxysmal Nocturnal Hemoglobinuria Compared to Ravulizumab

Regeneron Pharmaceuticals, Inc. (NASDAQ REGN) today announced positive updated Phase 3 data of an exploratory cohort from the ACCESS-1 trial investigating its f

Phase 2 Data From the Ongoing Hibiscus Study Shows Promise That Investigational Etavopivat Could Reduce the Incidence of Vaso-occlusive Crises in People With Sickle Cell Disease

Novo Nordisk today announced 52-week results from the phase 2 part of the ongoing phase 2 3 HIBISCUS study program of investigational etavopivat in people with

Merck’s Investigational Zilovertamab Vedotin in Combination With R-CHP Demonstrates Complete Response Rate of 100% at 1.75 mg/kg Dose in Phase 2 Trial of Previously Untreated Patients With Diffuse Large B-Cell Lymphoma

Merck (NYSE MRK), known as MSD outside of the United States and Canada, today announced the first presentation of data from the Phase 2 waveLINE-007 trial evalu

FDA Grants Revascor (Rexlemestrocel-L) Regenerative Medicine Advanced Therapy (RMAT) Designation in Children with Congenital Heart Disease

Mesoblast Limited (Nasdaq MESO ASX MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced the United States Food and Dr

Xenon Showcases New Long-Term Azetukalner Data from X-TOLE OLE Study

Xenon Pharmaceuticals Inc. (Nasdaq XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing th

Everything You Need to Know About Shingles & the Shingles Vaccine

Shingles can strike anyone who had chickenpox when they were young, and the intense pain that can accompany this body rash has sidelined many a senior. Here, on

Popular Keywords